NIH-funded research R01 grant

Mindfulness-based digital aftercare to support addiction recovery

Official title: Multi-Site Feasibility Trial of Smartphone-Based Mindfulness Treatment for Promoting Addiction Recovery

Funded at Yale University · NIH-11443402 · Data updated 2026-11-12

A digital mindfulness program delivered via a smartphone app to help adults stay sober after intensive addiction treatment.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionYale University
NIH-funded
Lab location1 site (New Haven, United States)
Project startAugust 28, 2026
Project endJuly 31, 2029
Funding year2026
Award (this year)$634,664
NIH project number1R01AT013980-01
Project IDNIH-11443402 on NIH RePORTER

Who could benefit from this research

Could help

Adults 21 years or older who have completed intensive treatment for substance use disorders and are seeking additional aftercare support.

Less likely to help

Individuals who are not using aftercare services or do not have access to smartphone-enabled interventions may see limited or no benefit.

What this research studies

This project tests a smartphone-based mindfulness treatment designed as aftercare for adults with substance use disorders who have completed an intensive treatment program. The study will enroll participants across multiple sites to examine how a digital MBT can reduce relapse risk and improve coping with cravings without needing in-person providers. The approach uses an accessible Android app to guide mindfulness exercises and track progress, aiming to reach individuals who struggle with aftercare access. If successful, the app could become a scalable option to support long-term recovery.

Why it matters

Potential benefit: If successful, patients could have a convenient, evidence-based tool to help prevent relapse after treatment.

How similar studies have gone: Prior trials suggest mindfulness-based treatments can reduce relapse, and digital delivery may increase accessibility, though broader real-world effectiveness remains to be demonstrated.

Where this research is happening

  • Yale University
    New Haven, United States
    Active

Researchers

  • Principal investigator: Roos, Corey — Yale University
  • Study coordinator: Roos, Corey

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.